The Zelta Podcast

The Zelta Podcast
Podcast Description
This series will explore how clinical data management is evolving to meet growing demands and industry pressures. Speaking with experts at Zelta by Merative, this series will hear insights on the ways to harness new technologies to build control and confidence in clinical data management. Hosted on Acast. See acast.com/privacy for more information.
Podcast Insights
Content Themes
The podcast covers key topics in clinical data management, emphasizing the implementation of artificial intelligence and machine learning technologies. Specific episodes, like 'AI and Supervised Machine Learning in Clinical Trials – Part 1', examine generative AI versus supervised machine learning models, discussing both their benefits and risks in clinical settings.

This series will explore how clinical data management is evolving to meet growing demands and industry pressures. Speaking with experts at Zelta by Merative, this series will hear insights on the ways to harness new technologies to build control and confidence in clinical data management.
Hosted on Acast. See acast.com/privacy for more information.
In episode two, we continue our conversation about AI and supervised machine learning in clinical trials with Walker Bradham, senior director of product management and design at Zelta by Merative. The discussion covers Zelta’s approach to AI, which is driven by use cases, the benefits of supervised ML for trials, and Zelta’s strategy and vision for AI.
Hosted on Acast. See acast.com/privacy for more information.

Disclaimer
This podcast’s information is provided for general reference and was obtained from publicly accessible sources. The Podcast Collaborative neither produces nor verifies the content, accuracy, or suitability of this podcast. Views and opinions belong solely to the podcast creators and guests.
For a complete disclaimer, please see our Full Disclaimer on the archive page. The Podcast Collaborative bears no responsibility for the podcast’s themes, language, or overall content. Listener discretion is advised. Read our Terms of Use and Privacy Policy for more details.